Pforzheim Tricuspid Valve Registry - Outcomes of Percutaneous Tricuspid Valve Repair

ConditionsTricuspid Regurgitation Right Heart Failure Cardiac Remodeling, Ventricular Cardiac Remodeling, Atrial

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorHelios Klinikum Pforzheim

About this trial

The Pforzheim Tricuspid Valve Registry study is designed to confirm the safety and performance of the TriClip™ device in a contemporary real-world setting in critically ill patients. The observational trial is a prospective, single arm, open-label, single-center, post market registry.

Eligibility criteria

Qualifiers

Subjects (>=18 years age) have severe tricuspid regurgitation and are symptomatic despite medical therapy.

Subjects eligible to receive the TriClip™

Subjects must provide written informed consent prior to study procedure.

Disqualifiers

Subjects participating in another clinical study that may impact the follow-up or results of this study.

Trial design

Treatments tested in this trial

Transcatheter edge-to-edge tricuspid valve repair

Treatment groups

200 Participants

are divided into 1 treatment group

Sponsors and collaborators

Helios Klinikum Pforzheim

Lead sponsor

Source ClinicalTrials.gov